Cargando…

Oral Sucrosomial Iron Is as Effective as Intravenous Ferric Carboxy-Maltose in Treating Anemia in Patients with Ulcerative Colitis

Anemia is a frequent complication of ulcerative colitis, and is frequently caused by iron deficiency. Oral iron supplementation displays high rates of gastrointestinal adverse effects. However, the formulation of sucrosomial iron (SI) has shown higher tolerability. We performed a prospective study t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bertani, Lorenzo, Tricò, Domenico, Zanzi, Federico, Baiano Svizzero, Giovanni, Coppini, Francesca, de Bortoli, Nicola, Bellini, Massimo, Antonioli, Luca, Blandizzi, Corrado, Marchi, Santino
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7917674/ https://www.ncbi.nlm.nih.gov/pubmed/33673371 http://dx.doi.org/10.3390/nu13020608

Ejemplares similares

Fecal Calprotectin Predicts Mucosal Healing in Patients With Ulcerative Colitis Treated With Biological Therapies: A Prospective Study
por: Bertani, Lorenzo, et al.
Publicado: (2020)

Efficacy of ferric carboxy maltose in treatment of iron deficiency/iron deficiency anaemia during pregnancy
por: Obaid, Mariam, et al.
Publicado: (2023)

Effect of ferric-carboxy maltose on oxygen kinetics and functional status in heart failure patients with iron deficiency
por: Dhoot, Sandip, et al.
Publicado: (2020)

Ig Glycosylation in Ulcerative Colitis: It’s Time for New Biomarkers
por: Capecchi, Riccardo, et al.
Publicado: (2021)

Response to Ustekinumab Therapy Is Associated with an Improvement of Nutritional Status in Patients with Crohn’s Disease †
por: Bertani, Lorenzo, et al.
Publicado: (2023)

P1495: A PHASE III, RANDOMISED CONTROLLED SAFETY, EFFICACY AND COST EFFECTIVENESS TRIAL OF INTRAVENOUS IRON ISOMALTOSIDE (I3R) AND FERRIC CARBOXY MALTOSE (FERIUMR) IN SUBJECTS WITH IRON DEFICIENCY ANEMIA
por: Harikrishnan, P, et al.
Publicado: (2023)

Influence of the Serotonin Transporter 5HTTLPR Polymorphism on Symptom Severity in Irritable Bowel Syndrome
por: Colucci, Rocchina, et al.
Publicado: (2013)

Oral Supplementation with Sucrosomial Ferric Pyrophosphate Plus L-Ascorbic Acid to Ameliorate the Martial Status: A Randomized Controlled Trial
por: Briguglio, Matteo, et al.
Publicado: (2020)

A Hospital Based Study to Access the Usefulness of Using the Combination Regime of the Ferric Carboxy Maltose, Vitamin B12 and Folic Acid as a Treatment of Severe Anemia among Pregnant Women in a Rural Tribal Community of South Gujarat
por: Maitri, Vayeda, et al.
Publicado: (2022)

Effect of Oral Supplementation of Healthy Pregnant Sows with Sucrosomial Ferric Pyrophosphate on Maternal Iron Status and Hepatic Iron Stores in Newborn Piglets
por: Mazgaj, Rafał, et al.
Publicado: (2020)

Sucrosomial® iron effectiveness in recovering from mild and moderate iron-deficiency anemia in the postpartum period
por: Antoine, Edu, et al.
Publicado: (2023)

Comparative Evaluation of Sucrosomial Iron and Iron Oxide Nanoparticles as Oral Supplements in Iron Deficiency Anemia in Piglets
por: Mazgaj, Rafał, et al.
Publicado: (2021)

Pros and Cons of the SeHCAT Test in Bile Acid Diarrhea: A More Appropriate Use of an Old Nuclear Medicine Technique
por: Fani, Bernardo, et al.
Publicado: (2018)

In Vitro and In Vivo Sucrosomial(®) Berberine Activity on Insulin Resistance
por: Lupo, Maria Giovanna, et al.
Publicado: (2022)

Sucrosomial Iron Supplementation for the Treatment of Iron Deficiency Anemia in Inflammatory Bowel Disease Patients Refractory to Oral Iron Treatment
por: Bastida, Guillermo, et al.
Publicado: (2021)

PB2249: SUCROSOMIAL IRON SUPPORT IN PATIENT WITH IRON DEFICIENCY ANEMIA IS HIGLY EFFECTIVE IN IMPROVING ANEMIA REDUCING ERYPTOSIS AND M1 MACROPHAGES POLARIZATION
por: giordano, G., et al.
Publicado: (2022)

Inflammatory Bowel Diseases: It's Time for the Adenosine System
por: Antonioli, Luca, et al.
Publicado: (2020)

Non-Invasive and Minimally Invasive Biomarkers for the Management of Eosinophilic Esophagitis beyond Peak Eosinophil Counts: Filling the Gap in Clinical Practice
por: Visaggi, Pierfrancesco, et al.
Publicado: (2023)

T.06.5 ONE YEAR OF USTEKINUMAB THERAPY IMPROVES NUTRITIONAL STATUS IN PATIENTS WITH CROHN’S DISEASE
por: Bertani, L., et al.
Publicado: (2022)

A Low-FODMAP Diet for Irritable Bowel Syndrome: Some Answers to the Doubts from a Long-Term Follow-Up
por: Bellini, Massimo, et al.
Publicado: (2020)

Sucrosomial(®) Iron Supplementation in Mice: Effects on Blood Parameters, Hepcidin, and Inflammation
por: Asperti, Michela, et al.
Publicado: (2018)

Sucrosomial(®) Iron: A New Generation Iron for Improving Oral Supplementation
por: Gómez-Ramírez, Susana, et al.
Publicado: (2018)

Ex Vivo and in Vivo Study of Sucrosomial(®) Iron Intestinal Absorption and Bioavailability
por: Fabiano, Angela, et al.
Publicado: (2018)

Low Fermentable Oligo- Di- and Mono-Saccharides and Polyols (FODMAPs) or Gluten Free Diet: What Is Best for Irritable Bowel Syndrome?
por: Bellini, Massimo, et al.
Publicado: (2020)

An integrated assessment of histopathological changes of the enteric neuromuscular compartment in experimental colitis
por: Ippolito, Chiara, et al.
Publicado: (2015)

Intravenous ferric carboxymaltose for the treatment of iron deficiency anemia
por: Friedrisch, João Ricardo, et al.
Publicado: (2015)

Ferric Carboxymaltose as Treatment in Women with Iron-Deficiency Anemia
por: Seid, Melvin H., et al.
Publicado: (2017)

Intravenous ferric derisomaltose for the treatment of iron deficiency anemia
por: Auerbach, Michael, et al.
Publicado: (2021)

Sucrosomial(®) Iron: An Updated Review of Its Clinical Efficacy for the Treatment of Iron Deficiency
por: Gómez-Ramírez, Susana, et al.
Publicado: (2023)

Oral high-dose sucrosomial iron vs intravenous iron in sideropenic anemia patients intolerant/refractory to iron sulfate: a multicentric randomized study
por: Giordano, Giulio, et al.
Publicado: (2020)

Individualized anemia management enhanced by ferric pyrophosphate citrate protocol
por: Chait, Yossi, et al.
Publicado: (2022)

Different sucrose-isomaltase response of Caco-2 cells to glucose and maltose suggests dietary maltose sensing
por: Cheng, Min-Wen, et al.
Publicado: (2014)

Chicago classification v4.0 protocol improves specificity and accuracy of diagnosis of oesophagogastric junction outflow obstruction
por: Visaggi, Pierfrancesco, et al.
Publicado: (2022)

NKG2A and COVID-19: another brick in the wall
por: Antonioli, Luca, et al.
Publicado: (2020)

Hospitalisation for Drug Infusion Did Not Increase Levels of Anxiety and the Risk of Disease Relapse in Patients with Inflammatory Bowel Disease during COVID-19 Outbreak
por: Bertani, Lorenzo, et al.
Publicado: (2021)

Clinical use of mean nocturnal baseline impedance and post-reflux swallow-induced peristaltic wave index for the diagnosis of gastro-esophageal reflux disease
por: Visaggi, Pierfrancesco, et al.
Publicado: (2022)

Effect of Sucrosomial(®) Iron and Iron Drop Diluted with Natural Fruit Juice on Microhardness of Primary Enamel
por: Sahebnazar, Nika, et al.
Publicado: (2022)

Reduction of costs for anemia-management drugs associated with the use of ferric citrate
por: Thomas, Anila, et al.
Publicado: (2014)

Ferric carboxymaltose: A revolution in the treatment of postpartum anemia in Indian women
por: Rathod, Setu, et al.
Publicado: (2015)

Clinical experience with ferric carboxymaltose in the management of anemia in acute gastrointestinal bleeding
por: Ballester-Clau, Raquel, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_l2oj6j07m4a1divr1usk1s2mr8